Author | Publication year | Design | Operative approaches | End points | Study size | Secondary UPJO | Uro-lithiasis | Country | Population | Mean age [years] | Percent female | Follow up [monts] |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Baldwin et al. [25] | 2003 | retrospective | EP, LP, OP | operative success, operating time, estimated blood loss, transfusion, complications, length of stay, analgesia requirement | 32 | LP 44%, EP 33%, OP 43% | NA | USA | adult | 44,4 and 37 and 42 | NA | 11,0 and 9,9 and 5,4 |
Bernie et al. [26] | 2005 | retrospective | LP, RP | operative success, operating time, estimated blood loss, complications, urinary leakage, length of stay | 14 | NA | NA | USA | adult | 34 and 32 | NA | 24 and 10 |
Bird et al. [27] | 2011 | prospective | LP, RP | operative success, operating time, suturing time, estimated blood loss, conversion, complications, length of stay | 172 | 13% overall | LP 16%, RP 30% | USA | adult | 39,7+/−14,6 | 53 | NA |
Brooks et al. [28] | 1995 | retrospective | EP, LP, OP | operative success, operating time, transfusion, re-operation, complications, length of stay, time to return to normal activity, analgesia requirement | 45 | EP 23%, LP 8%, OP 18% | EP 1%, LP 0%, OP 9% | USA | adult | 42 and 38,4 and 30,6 | 60 | 22,0 and 13,6 and 26,0 |
Calvert et al. [29] | 2008 | retrospective | LP, OP | operative success, operating time, conversion, complications, length of stay | 100 | OP 6%, LP 14% | NA | UK | adult | 36,5 | 77 | 9 and 12 |
Chen et al. [30] | 2016 | retrospective | EP, LP, OP | operative success, operating time, estimated blood loss, conversion, complications, urinary leakage, length of stay | 109 | NA | NA | China | children and adult | 32,8+/−15,6 and 30,9+/− 12,9 and 37,5+/− 12,0 | 39 | 51,9+/− 40,1 |
Danuser et al. [31] | 2012 | NA | LP, RP | operative success, operating time, conversion, complications, length of stay | 82 | NA | NA | Switzerland | NA | NA | NA | NA |
Desai et al. [14] | 2004 | retrospective | EP, LP | operative success, operating time, re-operation, complications, length of stay | 29 | none | NA | USA and India | adult | 38,6+/−16,1 and 38,9+/− 17 | 48 | 31,4+/− 12,6 and 20,0+/−14,0 |
Fahad [32] | 2017 | NA | LP, OP | operative success, operating time, conversion, re-operation, complications, urinary leakage, deaths, length of stay, time to return to normal activity, analgesia requirement | 40 | NA | NA | Iraq | children and adult | 24 | 35 | 9 |
Garcia-Galisteo et al. [33] | 2011 | retrospective | LP, RP | operative success, operating time, suturing time, estimated blood loss, transfusion, complications, deaths, length of stay | 50 | NA | NA | Spain | children and adult | 33,9 | 60 | 20,6 and 42,5 |
Han et al. [22] | 2008 | retrospective | EP, LP | operative success, operating time, transfusion, complications, length of stay, renal function | 45 | EP 31%, LP 13% | NA | Korea | adult | 45,22 and 49,5 ± 13,6 | 47 | 15,2 and 14,3 |
Hanske et al. [20] | 2015 | retrospective | LP, OP | transfusion, re-operation, complications, deaths | 593 | NA | NA | USA | adult | median 48 | 57 | 1 |
Hemal et al. [34] | 2010 | retrospective | LP, RP | operative success, operating time, suturing time, estimated blood loss, conversion, re-operation, complications, length of stay, time to return to normal activity, analgesia requirement | 60 | NA | NA | India | children and adult | 24,9 and 28,1 | 32 | 18 |
Klingler et al. [35] | 2003 | retrospective | LP, OP | operative success, re-operation, complications, pain, analgesia requirement | 55 | LP 8%, OP 0% | NA | Switzerland | adult | 35,9+/−21,1 and 41,0+/−27,9 | 60 | 19,4+/−9,1 and 17,9+/−8,8 |
Link et al. [36] | 2006 | prospective | LP, RP | operating time, complications, urinary leakage | 20 | none | NA | USA | adult | 46,5 and 38,0 | 65 | 5,6 |
Lucas et al. [16] | 2012 | retrospective | LP, RP | operative success, operating time, estimated blood loss, complications, urinary leakage | 759 | RP 27%, LP 24% | RP 18%, LP 12% | North America | NA | 35 | NA | 11+/−13 and 15+/− 16 |
Memon et al. [37] | 2016 | retrospective | LP, OP | operative success, operating time, estimated blood loss, complications, length of stay | 73 | none | NA | Pakistan | adult | 28 and 30 | 59 | 2,7+/−1,2 |
Mohammed [38] | 2017 | prospective | LP, OP | operative success, operating time, estimated blood loss, re-operation, length of stay | 55 | NA | NA | Germany | obese, NA | NA | NA | > 12 |
Olweny et al. [39] | 2012 | retrospective | LP, RP | operative success, operating time, estimated blood loss, conversion, complications, length of stay, analgesia requirement | 20 | none | NA | USA | adult | 40,3 and 35,8 | 57 | 2,8 and 9,2 |
Pahwa et al. [40] | 2014 | pro- and retrospective | LP, OP, RP | operative success, operating time, estimated blood loss, complications, length of stay | 90 | none | NA | India | adult | 31,4 and 34,4 and 32 | 33 | 32,0 and 18,0 and 13,5 |
Rivas et al. [15] | 2015 | retrospective | LP, OP | operative success, conversion, complications, deaths, length of stay | 92 | NA | LP 19%, OP 20% | Spain | adult | 44,5 and 38,5 | NA | 45 |
Simforoosh et al. [41] | 2004 | prospective | LP, OP | operative success, operating time, transfusion, re-operation, complications, urinary leakage, length of stay | 69 | none | NA | Iran | children and adult | 18,2 and 23,1 | 38 | 16,5 and 11,4 |
Umari et al. [42] | 2011 | retrospective | LP, OP | operative success, operating time, conversion, complications, length of stay | 49 | NA | LP 17%, OP 32% | Italy | children and adult | 42 | 51 | 72,3 and 40,9 |
Wang et al. [43] | 2013 | retrospective | LP, OP | operative success, operating time, estimated blood loss, complications, urinary leakage, length of stay, analgesia requirement | 172 | NA | NA | China | children and adult | 21 AND 25 years | 34 | 32,7 AND 38,4 months |
Weise and Winfield [44] | 2006 | prospective | LP, RP | operative success, operating time, estimated blood loss, transfusion, complications, length of stay | 45 | LP 7%, RP 0% | NA | USA | children and adult | 26 and 24,5 | 59 | 6 and 10 |
Yanke et al. [21] | 2008 | retrospective | EP, LP, RP | operative success | 273 | EP 29%; LP 28%, RP 31% | NA | USA | adult | NA | 61 | 20 and 20 and 19 |